Kate Burba News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Takeda s Entyvio snags second FDA approval as subcutaneous option for Crohn s disease

Takeda s Entyvio snags second FDA approval as subcutaneous option for Crohn s disease
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesFort worthTakeda entyvioTimothy ritterKate burbaSchool of medicineTakeda pharmaceuticalsGi alliance researchTakeda pharmaceutical entyvioBusiness unitEntyvio pen

Shared decision-making for IBD treatment should be patient centric , evidence-based

Shared decision-making for IBD treatment should be patient centric , evidence-based
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Kate burba healioHeather bieleBymonica stonehillPcrohn colitis congressUniversity of north carolina school medicineColitis congressNorth carolina schoolKate burba

Liver transplantation linked to lower antibody, T-cell response to COVID-19 vaccine

LONDON — Patients who received a liver transplant had significantly reduced antibody and T-cell responses to SARS-CoV-2 vaccination compared with healthy controls, according to research presented at the International Liver Congress.

United kingdomCity ofKate burbaThomas marjotOxford liver unit at university hospitalsInternational liver congressInternational liverOxford liver unitOxford university hospitals

DAA use decreases risk for cardiovascular events in patients with advanced fibrosis, HCV

LONDON — Direct-acting antiviral treatment correlated with a decreased risk for cardiovascular outcomes among patients with hepatitis C virus and advanced fibrosis but an increased risk for arrhythmias and conduction disorders. “Several studies have revealed that hepatitis C virus can induce chronic inflammation and immune dysregulation, and this immune dysregulation and chronic

France generalCity ofUnited kingdomKate burbaPublic health at sorbonne universityFrench national health insurance databasePierre louis institute of epidemiologyInternational liver congressPierre louis institutePublic healthSorbonne universityInternational liver

Younger-onset type 2 diabetes increases risk for liver-related events

LONDON — Younger-onset type 2 diabetes increased the risk for liver-related events among patients with nonalcoholic fatty liver disease, according to research presented at the International Liver Congress.

City ofUnited kingdomKate burbaXinrong zhangTerry yipChinese university of hong kongInternational liver congressInternational liverChinese universityHong kong